Feasibility and Pathologic Outcomes of Peripheral Lung Vascular Targeted Photodynamic Therapy in a Normal Porcine Lung Model.

Authors

Jason Beattie, Mario Ghosn, Kwanghee Kim, Raymond Parrish, Jie Chen, Stephen B Solomon, Sebastien Monette, Christopher Cheleuitte-Nieves, Reza Bergemann, Mohit Chawla, Bryan C Husta, Or Kalchiem-Dekel, Yaniv Cohen, Dina Preise, Zachary Sacks, Avigdor Scherz, Lonny Yarmus, Jonathan A Coleman, Robert P Lee

Published in

CHEST pulmonary. Volume 3. Issue 1. Pages 100098. Epub Aug 29, 2024.

Abstract

Bronchoscopic ablation of tumors in the lung periphery may offer unique advantages over traditional surgical resection or radiation. Bronchoscopic vascular targeted photodynamic therapy (VTP) is a second-generation photodynamic therapy that avoids excessive tissue extravasation and is rapidly cleared from the circulation. These advantages avoid prolonged photosensitivity and allow for infusion and illumination within the same procedure. The treatment effect and systemic inflammatory response precipitated by VTP may prove advantageous for anticancer effects, alone or in combination with immune oncology therapies.
A baseline understanding of this modality's effect on lung parenchyma is needed to provide further guidance toward its potential as a method for bronchoscopic ablation of lung tumors. We report on our initial experimentation with bronchoscopic lung VTP in normal pigs.
We performed conventional bronchoscopy for deployment of optical fibers into the peripheral lung. We then infused the photosensitizer WST11 after which we immediately performed illumination of the optical fibers.
Our results across 13 pigs with varied survival (between 1 day and 30 days) demonstrate initial feasibility and reasonable safety. Posttreatment radiology and pathology support measurable ablation fields and expected post-VTP changes.
Our preclinical evidence provides early rationale for the study of safety and feasibility of bronchoscopic VTP ablation of peripheral lung cancers in humans.

PMID:
42548454
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.